• Echosens
    North America
    is your innovation partner
    for non-invasive liver
    disease diagnostics

    Learn More
  • AASLD 2018 Update: Advancing Role of NIT in Liver Disease

    View On-Demand Recording


    The NEW platform that will allow you to customize your marketing materials and promote your Fibroscan services!

    Try now!
  • • Powered by VCTE and CAP
    ULTRA Mobile Device

    Expanding access to non-invasive
    liver disease management

    Learn More
  • The industry standard
    for the non-invasive
    assessment of
    liver diseases.

    Learn More
  • Dual Function
    Liver Diagnostics
    VCTE and CAP
    State-of-the-art of non-invasive
    liver diagnostics

    Learn More
  • Engineered with
    Smart Tools to support
    consistency, irrespective of
    operator and across most
    patient morphologies.

    Learn More
  • Learn more about the utility of FibroScan® from the experts.

    Visit our Video Library for more Webinars and Videos.

    Video Library

Expanding access to non-invasive liver disease management
The FibroScan® 430 Mini+ offers mobility with the same experience and consistent results that you have come to expect from the FibroScan®502 Touch and FibroScan 530 Compact systems.

Learn More →

Enhancing access through mobility
The FibroScan® 530 Compact offers the same dual function capabilities and examination experience as the FibroScan® 502 Touch.

Learn More →

Innovation in Liver Disease Management
Using patented Vibration Controlled Transient Elastography (VCTE), the FibroScan® 502 Touch is the first noninvasive device indicated for use as an aid in the clinical management of patients with liver disease.

Learn More →

Find a FibroScan®

In North America, there are more than 1000 FibroScan® systems. We’re growing fast!

Check out our map →

Find a Sales Rep

In North America, more than 20 sales rep are available for your FibroScan® system purchase.

Locate a Rep →

Echosens is now your direct partner in the United States.

Contact Us

Video Library

AASLD 2018 Update: Advancing Role of NITs in Liver Disease

Webinar: The Role of Elastography in Chronic Liver Disease: The AGA Guidelines

Using patented VCTE and CAP, FibroScan® is the first totally non-invasive device indicated for use as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. The examination with FibroScan® is rapid and easily repeatable over time. This unique, accurate and efficient device brings extra confidence to patient management.